Bio-Techne (TECH) Diagnostics And Spatial Biology — Restructuring Charges — Quarterly & Annual

Screener

Other segment segments

Protein Sciences

$2.12M+1,544%

Corporate

$688K+136%

Similar metrics at other companies

RPMCorporate And Other — Restructuring Charges

$1.52M—

MTXConsumer And Specialties — Restructuring Charges

$0-100%

HLFRetention And Separation — Restructuring Charges

$0-100%

TRIPHotels And Other — Restructuring Charges

$2.8M—

DCH

DCHDriveline — Restructuring Charges

$16.9M+1,590%

AAPReportable — Restructuring Charges

$32M-72.9%

Other financials

Income statement

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

Market cap$11.22B+43.5%

Enterprise value$11.3B+39.5%

P/E74.9×+16.9×

P/S9.3×+2.9×

Profitability

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed: May 6, 2026, 4:31 PM EDT
Fiscal quarter: Q3 FY2026
Calendar quarter: Q1 2026
Accession: 0001104659-26-056302

Line item	Employee / severance	Asset-related / and other	Recovery of / assets held-for-sale	Total
Protein Sciences	$$556	$1,565	—	2,121
Diagnostics and Spatial Biology	27	—	—	27
Corporate	454	234	—	688
Total	$$1,037	$1,799	—	2,836

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's diagnostics and spatial biology — restructuring charges?: Bio-Techne (TECH) reported diagnostics and spatial biology — restructuring charges of $27K in Q1 2026.
What does diagnostics and spatial biology — restructuring charges mean?: Reflects the costs associated with reorganizing, downsizing, or streamlining operations within the diagnostics and spatial biology segment. These charges often include severance, facility closures, or asset write-downs intended to improve future profitability. While they reduce current earnings, they are typically viewed as a strategic move to optimize the cost base.

Ask your AI about Bio-Techne's diagnostics and spatial biology — restructuring charges.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk